Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety, tolerability, and exploratory efficacy of OTO-413 administered as an intratympanic injection for the treatment of speech-in-noise hearing impairmen...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otonomy, Inc.
NCT05572073 · Sensorineural Hearing Loss, Bilateral
NCT07356128 · Bilateral Sensorineural Hearing Loss, Cochlear Implant, and more
NCT06936449 · Sensorineural Hearing Loss, Bilateral Hearing Loss
NCT04591093 · Sensorineural Hearing Loss, Bilateral
NCT06229717 · Children, Only, Vestibular Disorder, and more
Colorado Otolaryngology Associates LLC dba Colorado ENT & Allergy
Colorado Springs, Colorado
Research Centers of America
Hollywood, Florida
South Florida ENT Associates or Research Centers of America
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions